NexgenRX Inc. | Cash Flow
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
608.50
477.60
188.30
587.80
625.90
696.90
Depreciation, Depletion & Amortization
63.60
64.00
74.50
75.20
129.90
317.10
Other Funds
-
-
-
-
1.90
145.70
Funds from Operations
807.00
124.40
331.50
485.70
483.30
268.40
Changes in Working Capital
32.90
433.80
296.60
5.30
224.00
4,632.10
Net Operating Cash Flow
774.10
558.20
34.90
491.00
259.20
4,900.50
Capital Expenditures
67.30
78.70
104.00
355.00
462.50
Net Investing Cash Flow
67.30
78.70
104.00
355.00
462.50
Issuance/Reduction of Debt, Net
91.70
30.00
390.00
18.60
269.50
Net Financing Cash Flow
91.70
30.00
160.00
221.40
2,067.40
Net Change in Cash
615.10
666.90
21.10
357.40
1,345.60
Free Cash Flow
726.80
580.70
77.30
440.30
297.40
Deferred Taxes & Investment Tax Credit
-
-
-
175.00
-
34.30
Change in Capital Stock
-
-
550.00
240.00
1,796.00
About NexgenRX
View Profile
